Skip to content

POST OPERATIVE MANAGEMENT OF SHIVERING: A COMPARISON BETWEEN THE EFFICACY OF TRAMADOL AND PETHIDINE

POST OPERATIVE MANAGEMENT OF SHIVERING: A COMPARISON BETWEEN THE EFFICACY OF TRAMADOL AND PETHIDINE

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260428002
Enrollment
800
Registered
2026-04-28
Start date
2025-01-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The primary outcome measure was the improvement or prevention of postoperative shivering following administration of the study drug. The secondary outcome measure included the frequency of adverse effects associated with each medication. TURP, Pethidine, Tramadol

Interventions

To compare improvement in shivering, and frequency of adverse effects in geriatric patients undergoing trans-urethral resection of prostate (TURP).: A total of 860 patients were divided into Group-A t
Experimental Drug
Tramadol and Pethidine arms

Sponsors

None listed

Eligibility

Sex/Gender
Male
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Male patients aged 65 years (geriatric), scheduled for elective trans-urethral resection of the prostate (TURP) under spinal anesthesia, 2. Patients were hemodynamically stable at the time of treatment 3. Patients provided written informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with pre-existing fever 2. Patients with baseline hypothermia before spinal anesthesia 3. Patients with active infection/sepsis 4. Patients with known hypersensitivity to tramadol or pethidine/meperidine 5. Patients with chronic opioid use or opioid dependence 6. Patients with a history of seizure disorder 7. Patients with severe hepatic or renal impairment (risk of altered drug metabolism/clearance) 8. Patients with significant respiratory compromise or on room air 9. Patients with clinically significant cardiac instability (ongoing ischemia, uncontrolled arrhythmias, or decompensated heart failure) 10. Patients with cognitive impairment precluding valid consent/assessment 11. Patients using other anti-shivering drugs intra- or post-operatively 12. Patients who were converted to general anesthesia 13. Patients with major intra-operative complications, or refusal to participate.

Design outcomes

Primary

MeasureTime frame
consistent with contemporary anesthesia literature 3 hours Crossley and Mahajan shivering scale

Secondary

MeasureTime frame
Shivering 3 hours Crossley and Mahajan shivering scale

Countries

Pakistan

Contacts

Public ContactOsamah Ahmed

NUMS

ligerlynx@ymail.com03331592224

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026